Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)

NCT01170065 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Fibrosis

Interventions

DRUG: BIBF 1120
DRUG: BIBF 1120
DRUG: BIBF 1120
DRUG: BIBF 1120

Sponsor

Boehringer Ingelheim